If the antimicrobial use of phages is to move beyond ad hoc compassionate cases, the Government and its agencies should reflect on what role they are to play in the fight against AMR. At the moment, phages are referred to in the AMR strategy, as one approach amongst others. However, we believe that the Government and its agencies should make a more definitive and positive statement on phages. Clarity is imperative for research funding decisions and for private investment in commercial phages.